Aydemir, SelahattinAfshar, Milad TorkamanianAfshar, Ozlem Sari TorkamanianCengiz, Zeynep TasKiraz, MustafaBaydar, CanerYilmaz, Hasan2025-05-102025-05-1020242792-055010.4274/ArchEpilepsy.2023.231022-s2.0-85197417693https://doi.org/10.4274/ArchEpilepsy.2023.23102https://hdl.handle.net/20.500.14720/10716Kiraz, Mustafa/0000-0002-6322-4621Objectives: This study was conducted to evaluate the relationship between toxoplasmosis and cryptogenic epilepsy (CE) by comparing the rate of Toxoplasma gondii seropositivity identified in CE patients with those without any neurological disorder. Methods: The study included 200 cryptogenic patients and 164 individuals without neurological disorders. T. gondii seropositivity was studied in individuals Results: The study found T. gondii IgG in 15.50% of CE patients and 28.66% of individuals without any neurological disorder. The difference between the two Conclusion: Toxoplasmosis did not increase the risk of epilepsy in the region where this study was conducted. However, for a better understanding of the CE-T. gondii relationship, we believe that seroprevalence studies should be conducted in larger populations.eninfo:eu-repo/semantics/openAccessCryptogenic EpilepsyDopamineGabaNeurologyToxoplasmosisEvaluation of Toxoplasma Gondii in the Etiology of Cryptogenic Epilepsy: a Case-Control StudyArticle302N/AQ439421260363WOS:001262553600001